On February 13, 2026, Ambrosia Brands, LLC, recalled lots of Rosabella-brand moringa powder capsules. The recalled product was available for sale nationwide and internationally. The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Newport infections linked to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC. Based on epidemiological information collected by the CDC, a total of seven people infected with the outbreak strain of Salmonella have been reported from seven states (AZ, FL, IA, IL, IN, TN, WA). Illnesses started on dates ranging from November 7, 2025, to January 8, 2026. Of the three people interviewed, three (100%) reported eating Rosabella-brand moringa powder capsules. There have been three hospitalizations, and no deaths have been reported. The Salmonella strain associated with this outbreak is resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections. The FDA has recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules from the market, and the firm has agreed to recall some lots. @ https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-extensively-drug-resistant-salmonella-moringa-powder-february-2026?utm_medium=email&utm_source=govdelivery
